OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the Financial Times’ prestigious ‘UK Best Employers 2025’ list. This recognition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback